Hennigsdorf, Germany

Intersect Ent Gmbh


Patents = 47

Trademarks = 17

Forward Citations = 2,560


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


35 inventors (with patents filed for the assignee):


Intersect ENT GmbH is a biotechnology company focused on providing innovative solutions for patients with ear, nose, and throat (ENT) conditions. With a mission to improve the quality of life for patients suffering from chronic sinusitis, Intersect ENT GmbH develops and commercializes advanced products that enable minimally invasive treatments. Their flagship product, PROPEL sinus stent, helps maintain sinus openings and improve post-surgical outcomes. Intersect ENT GmbH is committed to advancing the treatment options available to ENT specialists and providing relief to patients.
This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com
Loading…